SavedAdd your journal

Journals / Journal of Neurological Sciences (Turkish) / 2006 / Cilt: 23 - Sayı: 4

Meningiomalarda proliferatif mıb-1 indeksi:histolojik alt tipler ve dereceleri ile ilişkisi

Proliferative indices (mib-1) in meningiomas: Correlation with the histological subtypes and grades

Pınar KARABAĞLI
Aydın SAV
Pages
279–286
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results were analyzed using statistical methods and discussed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:We examined the proliferative potentials of meningiomas in 87 patients using the MIB-1 antibody against the Ki-67 antigen and compared them with the histopathologic subtypes and grades.
📊
Key Findings & Data:Values of MIB-1 labeling indices (LIs) seem to parallel degree of histologic malignancy in many tumors, including meningioma.
💡
Conclusion & Impact:Results were analyzed using statistical methods and discussed.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

We examined the proliferative potentials of meningiomas in 87 patients using the MIB-1 antibody against the Ki-67 antigen and compared them with the histopathologic subtypes and grades. Values of MIB-1 labeling indices (LIs) seem to parallel degree of histologic malignancy in many tumors, including meningioma. The growth potential of meningiomas is variable. MIB-1 LI of meningiomas is correlated with regrowth potential and tumor doubling time. In our study, histological grading of the meningiomas according to the latest World Health Organization clasification included the cases of 49 grade I, of 31 grade II, and of 7 grade III. The mean ± SD MIB index was 2.23±2.31 in grade I meningiomas, and those of grade II and grade III meningiomas were 6.53±5.31 and 11.1±7.8, respectively. There was a correlation between the values of MIB-1 LI and the histological grades. Meningiomas have also a wide range of histopathological appearances. Some differences for MIB-1 labeling indices were found among the subtypes of meningiomas of same grade. Results were analyzed using statistical methods and discussed.

Özet

87 hastada meningiomaların proliferasyon potansiyelerini Ki-67 antijenine karşı MIB-1 antikoru kullanarak inceledik ve bu değerleri, meningiomaların histopatolojik alt tipleri ve dereceleri ile karşılaştırdık. MIB-1 bağlanma indeksi, meningioma dahil birçok tümörde histolojik olarak malignite derecesi ile parallel gibi görünmektedir. Meningiomalarda büyüme potansiyeli farkılıklar gösterir. MIB-1 bağlanma indeksi meningiomalarda tümörün yeniden büyüme potansiyeli ve tümör ikiye katlanma (doubling) zamanı ile koreledir. Çalışmamız histolojik olarak en son Dünya Sağlık Örgütü dereceleme sistemine (2000) göre 49 adet derece I, 31 adet derece II ve 7 adet derece III meningioma olgusu kapsamaktadır. Derece I meningiomalarda MIB-1 bağlanma indeksi ‘ortalama ± standart sapma’ değeri 2.23±2.31 iken, derece II ve derece III meningiomalarda sırası ile 6.53±5.31 ve 11.1±7.8 bulundu. MIB-1 bağlanma indeksi değerleri ve histolojik dereceleri arasında ilişki saptandı. Meningiomalar geniş bir histopatolojik görünüm spekturumuna da sahiptirler. Aynı derecede olmalarına rağmen meningioma olgularının histopatolojik alt tipleri arasında, farklı MIB-1 bağlanma indeksleri saptandı. Sonuçlar istatistiksel yöntemler ile analiz edilerek tartışıldı.

🔖

Cite This Article

KARABAĞLI, P., SAV, A. (2022). Meningiomalarda proliferatif mıb-1 indeksi:histolojik alt tipler ve dereceleri ile ilişkisi. Journal of Neurological Sciences (Turkish), Cilt: 23 - Sayı: 4, 279–286. https://ajindex.com/articles/565703

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Abramovich CM, Prayson RA. Histopathologic features and MIB-1 labeling indices in recurrent and nonrecurrent meningiomas. Arch Pathol Lab Med 1999; 123: 793-800
  2. Amatya VJ, Takeshima Y, Sugiyama K, Nishisaka T, Fuku T, Inai K. Immunohistochemical study of Ki-67 (MIB-1), p53 protein, p21WAF1, and p27KIP1 expression in benign, atypical, and anaplastic meningiomas. Hum Pathol. 2001;32(9):970-975
  3. Bruner JM, Langford LA, Fuller GN. Neuropathology, cell biology, and newer diagnostic methods. Current Opinion in Oncology 1993;5:441-449
  4. Colakoglu N, Demirtas E, Oktar N, Yuntem N, Islekel S, Ozdamar N. Secretory meningiomas. J Neurooncol 2003;62(3):233-241
  5. Coons SW, Johnson PC, Pearl DK.The prognostic significance of Ki-67 labeling indices for oligodendrogliomas. Neurosurgery 1997; 41(4); 878-885
  6. Dirks PB, Rutka JT. Current concepts in neuro-oncology:The cell cycle-a review. Neurosurg. 1997;40(5):1000-1013
  7. Ferraraccio F, Accardo M, Giangaspero F, Cuccurullo L. Recurrent and atypical meningiomas—a multiparametric study using Ki67 labelling index, AgNOR and DNA Feulgen staining. Clin Neuropathol. 2003;22(4):187-92
  8. Hinton DR. Dıagnostic immunohistochemistry of the nervous system. In: Taylor CR, Cote RJ, editors. Immunomicroscopy: A Dıagnostic Tool for the Surgical Pathologist. 2nd ed. U.S.A:Saunders, 1994;346-349
  9. Hitchcock CL. Ki-67 staining as a means to simplify analysis of tumor cell proliferation. Am. J. Clin. Pathol. 1991;96:444-446
  10. Kaala JP, Caemaert J, De Ridder L. Primary resected meningiomas:relapses and proliferation markers. In Vivo. 2004;18(4):411-6
  11. Karamitopoulou E, Perentes E, Tolnay M, Probst A. Prognostic significance of MIB-1, p53, and bcl-2 immunoreactivity in meningiomas. Hum Pathol. 1998;29(2):140-145
  12. Kayaselcuk F, Zorludemir S, Gumurdulu D, Zeren H and Erman T. PCNA and Ki-67 in nervous system tumors:correlation with the histological type and grade. J Neuro-Oncol 2002;57:115-121
  13. Kolles H, Niedemayer I, Schmitt C, Henn W, Feld R, Steudel WI, Zang KD, Feiden W. Triple approach for diagnosis and grading of meningomas: histology, morphometry of Ki-67/Feulgen stainings, and cytogenetics. Acta Neurochir (Wien)1995;137 (3-4):174-181
  14. Lamszus K, Lengler U, Schmidt NO, Stavrou D, Ergun S, Westpal M. Vascular Endothelial growth factor, Hepatocyte Growth factor, Basic fibroblast growth factor and Placenta growth factor in human meningiomas and their relation to angiogenesis and malignancy. Neurosurge